XML 69 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 4 Months Ended 8 Months Ended 12 Months Ended
Dec. 31, 2018
Aug. 27, 2018
Dec. 31, 2019
Cash flows from financing activities:      
Cash and cash equivalents, beginning of period     $ 176,421
Cash and cash equivalents, end of period $ 176,421   6,611,928
Successor      
Cash flows from operating activities:      
Net income (loss) 138,286   (2,835,778)
Adjustments to reconcile net income to net cash used in operating activities      
Depreciation and amortization 511   119,951
Interest expense on convertible debt 0   61,934
Loss on disposal of asset 0   15,944
Bad debt expense 0   110,000
Recognition of vesting stock option expense 0   0
Changes in assets and liabilities:      
(Increase) decrease in accounts receivable (1,022,500)   (324,368)
(Increase) decrease in inventory (16,803)   (281,205)
(Increase) decrease in prepaid and other assets (26,446)   (455,960)
Increase (decrease) in accounts payable 156,727   (65,037)
Increase (decrease) in accounts payable related parties 36,203   (19,599)
Increase (decrease) in accrued royalties and expenses 228,606   282,004
Increase (decrease) in accrued liabilities 701,125   1,224,713
Net cash flows provided by (used in) operating activities 195,709   (2,167,401)
Cash flows from investing activities:      
Purchase of property and equipment (19,288)   (182,825)
Cash received in reverse acquisition 0   508,973
Repurchase and cancellation of fractional shares 0   (1,061)
Proceeds from disposal of assets 0   301
Purchase of intangible assets 0   (1,522,485)
Net cash flows used in investing activities (19,288)   (1,197,097)
Cash flows from financing activities:      
Draw on line of credit 0   2,200,000
Payment on line of credit 0   (2,200,000)
Private placement stock issue 0   10,000,005
Advance on future noncontrolling interest distribution 0   (200,000)
Net cash flows provided by financing activities 0   9,800,005
Net increase in cash 176,421   6,435,507
Cash and cash equivalents, beginning of period 0   176,421
Cash and cash equivalents, end of period 176,421 $ 0 6,611,928
Cash paid during the period for:      
Interest 0   43,985
Income Taxes 0   0
Supplemental non-cash investing and financing activities:      
Common stock issued for dividends on Series C Preferred Stock 0   0
Common stock issued for conversion of Series C Preferred Stock 0   0
Common stock issued for conversion of Related Party debt and interest 0   0
Preferred Shares issued for inventory contribution 448,511   0
Common stock issued in reverse capitalization; less cash received of $508,973 0   $ 1,666,537
Predecessor      
Cash flows from operating activities:      
Net income (loss)   37,178  
Adjustments to reconcile net income to net cash used in operating activities      
Depreciation and amortization   56,425  
Interest expense on convertible debt   60,608  
Loss on disposal of asset   0  
Bad debt expense   12,558  
Recognition of vesting stock option expense   14,867  
Changes in assets and liabilities:      
(Increase) decrease in accounts receivable   (313,969)  
(Increase) decrease in inventory   262,886  
(Increase) decrease in prepaid and other assets   (23,320)  
Increase (decrease) in accounts payable   189,388  
Increase (decrease) in accounts payable related parties   (36,097)  
Increase (decrease) in accrued royalties and expenses   (170,467)  
Increase (decrease) in accrued liabilities   231,313  
Net cash flows provided by (used in) operating activities   321,370  
Cash flows from investing activities:      
Purchase of property and equipment   (8,482)  
Cash received in reverse acquisition   0  
Repurchase and cancellation of fractional shares   0  
Proceeds from disposal of assets   0  
Purchase of intangible assets   0  
Net cash flows used in investing activities   (8,482)  
Cash flows from financing activities:      
Draw on line of credit   0  
Payment on line of credit   0  
Private placement stock issue   0  
Advance on future noncontrolling interest distribution   0  
Net cash flows provided by financing activities   0  
Net increase in cash   312,888  
Cash and cash equivalents, beginning of period $ 776,077 463,189  
Cash and cash equivalents, end of period   776,077  
Cash paid during the period for:      
Interest   0  
Income Taxes   0  
Supplemental non-cash investing and financing activities:      
Common stock issued for dividends on Series C Preferred Stock   15,007  
Common stock issued for conversion of Series C Preferred Stock   85,561  
Common stock issued for conversion of Related Party debt and interest   1,585,594  
Preferred Shares issued for inventory contribution   0  
Common stock issued in reverse capitalization; less cash received of $508,973   $ 0